Published in AIDS Weekly, December 18th, 1995
"Ritonavir monotherapy appears to be well-tolerated and is associated with potent antiviral effects and immunologic benefit in AIDS patients. Expanded clinical trials of ritonavir are needed," said Martin Markowitz, M.D., staff investigator at New York's Aaron Diamond AIDS Research Center and principal author of the article.
The study was a 12-week...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.